Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania

Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania

Background. The severity of malaria infection depends on the host, parasite and environmental factors. Merozoite surface protein (msp) diversity determines transmission dynamics, P. falciparum immunity evasion, and pathogenesis or virulence. There is limited updated information on P. falciparum msp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Karol J. Marwa, Eric Lyimo, Eveline T. Konje, Anthony Kapesa, Erasmus Kamugisha, Göte Swedberg
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Tropical Medicine
Online Access:	http://dx.doi.org/10.1155/2022/5089143
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
by: Fernanda G. Versiani, et al.
Published: (2013-01-01)

Interferon-γ and Interleukin-10 Responses during Clinical Malaria Episodes in Infants Aged 0–2 Years Prenatally Exposed to Plasmodium falciparum: Tanzanian Birth Cohort
by: Boniphace Sylvester, et al.
Published: (2018-01-01)

Status of the Multidrug Resistance-1 Gene of Plasmodium falciparum in Four Malaria Epidemiological Strata, Two Decades after the Abolition of Chloroquine as First-Line Treatment for Uncomplicated Malaria in Cameroon
by: David Denis Sofeu-Feugaing, et al.
Published: (2023-01-01)

The Immunological Plasmodium falciparum Malaria Characteristics of Children in Tajikistan Republic
by: Nighina M. Khodzhaeva, et al.
Published: (2019-01-01)

On the estimation of sequestered infected erythrocytes in Plasmodium falciparum malaria patients
by: Derdei Bichara, et al.
Published: (2014-02-01)

Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana
by: Richmond Afoakwah, et al.
Published: (2016-01-01)

Genetic diversity of Plasmodium falciparum reticulocyte binding protein homologue-5, which is a potential malaria vaccine candidate: baseline data from areas of varying malaria endemicity in Mainland Tanzania
by: Angelina J. Kisambale, et al.
Published: (2025-01-01)

Anemia, Thrombocytopenia, and Changes in Biochemical Parameters Occurring in Patients with Uncomplicated Plasmodium falciparum Malaria: Data Analysis from Antimalarial Efficacy-Randomized Trials in Dakar and Kaolack Regions, Senegal
by: Khadime Sylla, et al.
Published: (2022-01-01)

Severe Case of Plasmodium falciparum Malaria in a Pregnant Woman from Nigeria
by: Kruti Yagnik, et al.
Published: (2019-01-01)

Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets
by: Asrar Alam
Published: (2014-01-01)

Plasmodium falciparum Malaria Complicated by Symmetrical Peripheral Gangrene, Bowel Ischemia, Repeated Candidemia, and Bacteraemia
by: Emeline Masse, et al.
Published: (2014-01-01)

Trafficked Proteins—Druggable in Plasmodium falciparum?
by: Jasmin Lindner, et al.
Published: (2013-01-01)

Deep learning-based malaria parasite detection: convolutional neural networks model for accurate species identification of Plasmodium falciparum and Plasmodium vivax
by: Diego A. Ramos-Briceño, et al.
Published: (2025-01-01)

Plasmodium Falciparum Genetic Diversity and Multiplicity of Infection Among Asymptomatic and Symptomatic Malaria-Infected Individuals in Uganda.
by: Mwesigwa, Alex, et al.
Published: (2024)

Genetic diversity and population structure of Plasmodium falciparum across areas of varied malaria transmission intensities in Uganda.
by: Mwesigwa, Alex, et al.
Published: (2025)

Contrasting vector competence of three main East African Anopheles malaria vector mosquitoes for Plasmodium falciparum
by: Prisca A. Kweyamba, et al.
Published: (2025-01-01)

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
by: Deirdre Larkin, et al.
Published: (2009-03-01)

On Programmed Cell Death in Plasmodium falciparum: Status Quo
by: Dewaldt Engelbrecht, et al.
Published: (2012-01-01)

YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates
by: Inés Bouzón-Arnáiz, et al.
Published: (2025-01-01)

Temporal Changes in Plasmodium Falciparum Genetic Diversity and Multiplicity of Infection Across Three Areas of Varying Malaria Transmission Intensities in Uganda.
by: Mwesigwa, Alex, et al.
Published: (2025)

Hospitalization outcomes in people living with HIV on Dolutegravir-based regimen in Mwanza, Tanzania: a comparative cohort
by: Godfrey A. Kisigo, et al.
Published: (2025-02-01)

Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum
by: Tabish Qidwai, et al.
Published: (2014-01-01)

Clarification of factors associated with post-artesunate delayed hemolysis (PADH): Analysis of 327 patients with severe imported Plasmodium falciparum malaria in France
by: Pierre-Louis Conan, et al.
Published: (2025-03-01)

Healthy lifestyle factors and male perpetration of intimate partner violence: a cross-sectional study in Mwanza, Tanzania
by: Anna E. Jacob, et al.
Published: (2024-12-01)

Retracted: Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum
by: Biochemistry Research International
Published: (2022-01-01)

Paludismo por Plasmodium falciparum. Presentación de un caso importado
by: Sahily de la Caridad Ortega Medina, et al.
Published: (2018-06-01)

Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.
by: Lucy B Ochola, et al.
Published: (2011-03-01)

Recrudescence of Plasmodium malariae after Quinine
by: Irfanali R. Kugasia, et al.
Published: (2014-01-01)

Salivary Glands Proteins Expression of Anopheles dirus A Fed on Plasmodium vivax- and Plasmodium falciparum-Infected Human Blood
by: Saowanee Cotama, et al.
Published: (2013-01-01)

A Study of Synergy of Combination of Eosin B with Chloroquine, Artemisinin, and Sulphadoxine-Pyrimethamine on Plasmodium falciparum In Vitro and Plasmodium berghei In Vivo
by: Sedigheh Sadeghi, et al.
Published: (2020-01-01)

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
by: Abraham Rexford Oduro, et al.
Published: (2019-01-01)

Thrombocytopenia in Plasmodium vivax Malaria: How Significant?
by: Arti Muley, et al.
Published: (2014-01-01)

Lipid Profile of Children with Malaria by Plasmodium vivax
by: Rosa Maria Dias, et al.
Published: (2016-01-01)

Fatal Plasmodium falciparum, Clostridium perfringens, and Candida spp. Coinfections in a Traveler to Haiti
by: Gillian L. Genrich, et al.
Published: (2009-01-01)

Differential Gene Expression Profile of Human Neutrophils Cultured with Plasmodium falciparum-Parasitized Erythrocytes
by: Mohamad Alaa Terkawi, et al.
Published: (2018-01-01)

Spatiotemporal analysis of Plasmodium falciparum erythrocyte binding antigen-175 gene dimorphism in Ghana
by: Abraham Y. Kpirikai, et al.
Published: (2025-01-01)

Genetic Polymorphism of msp1 and msp2 in Plasmodium falciparum Isolates from Côte d’Ivoire versus Gabon
by: William Yavo, et al.
Published: (2016-01-01)

Emerging malaria in Indonesia: An overview of Plasmodium knowlesi infections
by: Nisa Fauziah, et al.
Published: (2025-02-01)

High Seropositivity of Brucella melitensis Antibodies among Pregnant Women Attending Health Care Facilities in Mwanza, Tanzania: A Cross-Sectional Study
by: Helmut A. Nyawale, et al.
Published: (2023-01-01)

Assessment of different genotyping markers and algorithms for distinguishing Plasmodium falciparum recrudescence from reinfection in Uganda.
by: Mwesigwa, Alex, et al.
Published: (2025)